p16INK4a and p19INK4d mRNA expression in neuroglial tumours: correlation with Ki67 proliferation index
- 1 October 1999
- journal article
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 25 (5), 408-416
- https://doi.org/10.1046/j.1365-2990.1999.00203.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Loss of p16/INK4A Protein Expression in Non-Hodgkin's Lymphomas Is a Frequent Finding Associated with Tumor ProgressionThe American Journal of Pathology, 1998
- CDKN2A Gene Deletions and Loss of p16 Expression Occur in Osteosarcomas That Lack RB AlterationsThe American Journal of Pathology, 1998
- Increased p16 expression with first senescence arrest in human mammary epithelial cells and extended growth capacity with p16 inactivationOncogene, 1998
- The human protein p19ARF is not detected in hemopoietic human cell lines that abundantly express the alternative β transcript of the p16INK4a/MTS1 geneOncogene, 1997
- Common alternative gene alterations in adult malignant astrocytomas, but not in childhood primitive neuroectodermal tumors: P16ink4 homozygous deletions and CDK4 gene amplificationsJournal of Neurosurgery, 1996
- Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibitionNature, 1995
- Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancersNature, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Negative Regulation of G1 in Mammalian Cells: Inhibition of Cyclin E-Dependent Kinase by TGF-βScience, 1993